ALX Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO

Jason Lettmann

CEOJason Lettmann

Employees

Employees80

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees80

ALXO Key Statistics

Market cap

24.37M

Market cap24.37M

Price-Earnings ratio

-0.18

Price-Earnings ratio-0.18

Dividend yield

—

Dividend yield—

Average volume

361.41K

Average volume361.41K

High today

$0.496

High today$0.496

Low today

$0.4502

Low today$0.4502

Open price

$0.4799

Open price$0.4799

Volume

264.32K

Volume264.32K

52 Week high

$8.78

52 Week high$8.78

52 Week low

$0.4051

52 Week low$0.4051

People also own

Based on the portfolios of people who own ALXO. This list is generated using Robinhood data, and it’s not a recommendation.